rs774486213

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_152891.3(PRSS33):​c.469G>C​(p.Gly157Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000689 in 1,451,242 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G157A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000069 ( 0 hom. )

Consequence

PRSS33
NM_152891.3 missense

Scores

3
7
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.292

Publications

0 publications found
Variant links:
Genes affected
PRSS33 (HGNC:30405): (serine protease 33) Enables serine-type endopeptidase activity. Involved in protein kinase C signaling and proteolysis. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.827

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRSS33NM_152891.3 linkc.469G>C p.Gly157Arg missense_variant Exon 5 of 7 ENST00000682474.1 NP_690851.2 Q8NF86

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRSS33ENST00000682474.1 linkc.469G>C p.Gly157Arg missense_variant Exon 5 of 7 NM_152891.3 ENSP00000507560.1 Q8NF86

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152128
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000339
AC:
2
AN:
59000
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000427
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000693
AC:
9
AN:
1299114
Hom.:
0
Cov.:
33
AF XY:
0.00000471
AC XY:
3
AN XY:
637490
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26236
American (AMR)
AF:
0.00
AC:
0
AN:
20268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19388
East Asian (EAS)
AF:
0.0000937
AC:
3
AN:
32006
South Asian (SAS)
AF:
0.0000602
AC:
4
AN:
66412
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
31424
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3806
European-Non Finnish (NFE)
AF:
0.00000191
AC:
2
AN:
1045774
Other (OTH)
AF:
0.00
AC:
0
AN:
53800
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152128
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41430
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67992
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000110
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 29, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.469G>C (p.G157R) alteration is located in exon 4 (coding exon 4) of the PRSS33 gene. This alteration results from a G to C substitution at nucleotide position 469, causing the glycine (G) at amino acid position 157 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
14
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.54
D;D;D
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.67
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.43
.;T;T
M_CAP
Pathogenic
0.31
D
MetaRNN
Pathogenic
0.83
D;D;D
MetaSVM
Uncertain
0.080
D
MutationAssessor
Uncertain
2.2
M;M;.
PhyloP100
0.29
PrimateAI
Uncertain
0.77
T
PROVEAN
Pathogenic
-7.7
D;.;.
REVEL
Benign
0.28
Sift
Uncertain
0.0010
D;.;.
Sift4G
Uncertain
0.0030
D;D;.
Polyphen
1.0
D;D;.
Vest4
0.18
MutPred
0.75
Gain of solvent accessibility (P = 0.0097);Gain of solvent accessibility (P = 0.0097);.;
MVP
0.65
MPC
0.71
ClinPred
0.43
T
GERP RS
1.5
Varity_R
0.50
gMVP
0.68
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs774486213; hg19: chr16-2835421; API